tradmap

ENOV Enovis Corp

$20.62 +3.51%

Data as of close

Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Enovis Corp (ENOV) is a healthcare company in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, with a market capitalization of $1.2 billion. Shares last traded at $20.62, 36.1% below their 52-week high. Over the past year the stock is down 32.9%. Net profit margin is -48.0%, below the peer median of 5.3%. Revenue grew 6.7% year over year.

Market Cap
$1.2B
Shares Out
57.7M
EPS (TTM)
-$19.30
P/E (TTM)*
—
P/S Ratio
0.52
P/B Ratio
0.81
Dividend / Share
—
Dividend Yield
—
52-Week High
$32.27
52-Week Low
$16.70
Volume (venue)
262,834
Avg Vol (3m, venue)
95,449.27

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-2.55%
1M
+16.07%
3M
-33.15%
6M
-11.77%
YTD
-22.54%
1Y
-32.88%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
52.19
SMA (50)
$19.90
SMA (200)
$23.06
Price vs SMA50
+3.61%
Price vs SMA200
-10.58%
ATR (14)
$1.08

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$2.3B
Net Income
-$1.1B
Gross Margin
61.1%
Operating Margin
-45.1%
Net Margin
-48.0%
Return on Equity
-74.6%
Return on Assets
-29.3%
Current Ratio
1.98
Debt / Equity
0.87
Revenue Growth (YoY)
+6.7%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-07-03. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 -$0.02 2026-08-06
Q1 2026 -$0.15 2026-05-07
Q4 2025 (derived) -$9.14 2026-02-26
FY 2025 -$20.75 2026-02-26
Q3 2025 -$9.99 2025-11-06
Q2 2025 -$0.64 2025-08-07

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Orthopedic, Prosthetic & Surgical Appliances & Supplies peers

ENOV vs 14 industry peers (Orthopedic, Prosthetic & Surgical Appliances & Supplies), by market cap. Data as of close

P/S vs peers
0.52 / 2.67 med
-81% discount
Net margin vs peers
-48.0% / 5.3% med
below median
1–14 of 14
ISRGIntuitive Surgical$151.5B51.2313.0825.5%+1.13%
EWEdwards Lifesciences$53.7B53.498.2515.4%+1.35%
STESteris$22.7B28.253.7713.3%+2.70%
ZBHZimmer Biomet$18.6B23.012.189.5%+2.98%
ALGNAlign Technology$11.0B26.482.6510.0%+2.86%
MSAMsa Safety Inc$7.2B22.983.7116.1%+4.76%
ESTAEstablishment Labs Holdings Inc.$1.8B—7.40-15.8%-2.14%
CDRECadre Holdings, Inc.$1.4B37.461.975.3%+4.02%
ENOVEnovis Corp$1.2B—0.52-48.0%+3.51%
AVRAnteris Technologies Global Corp.$562M—250.82—-8.63%
SMTISanara MedTech Inc.$296M—2.69-29.2%-1.98%
INGNInogen Inc$182M—0.60-8.1%+0.00%
LAKELAKELAND INDUSTRIES INC$89M—0.47-14.0%+1.24%
NTRBNutriBand Inc.$77M———+1.04%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.